AN2 Therapeutics, Inc.
ANTX
$1.25
-$0.04-3.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.07% | -24.55% | 9.74% | 29.03% | 11.70% |
| Total Receivables | -78.57% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.36% | 25.94% | -11.48% | 19.02% | -27.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.94% | -22.72% | 9.40% | 28.78% | 12.05% |
|
|
|||||
| Total Current Assets | -21.94% | -22.72% | 9.40% | 28.78% | 12.05% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.91% | -- | 44.86% | 35.81% | 44.86% |
| Total Assets | -33.63% | -36.49% | 9.66% | 33.13% | 35.28% |
|
|
|||||
| Total Accounts Payable | 23.95% | -64.92% | -39.80% | -31.37% | 26.11% |
| Total Accrued Expenses | -42.70% | -21.76% | -1.78% | 60.30% | 113.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 18.41% | 30.64% | 186.67% | 505.66% | 11,033.33% |
| Total Other Current Liabilities | 18.41% | 30.64% | 186.67% | 505.66% | 11,033.33% |
| Total Current Liabilities | -27.10% | -32.50% | -9.26% | 24.48% | 95.42% |
|
|
|||||
| Total Current Liabilities | -27.10% | -32.50% | -9.26% | 24.48% | 95.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -27.10% | -32.50% | -9.27% | 24.47% | 95.37% |
|
|
|||||
| Common Stock & APIC | 3.12% | 3.31% | 36.01% | 50.00% | 50.37% |
| Retained Earnings | -33.23% | -44.12% | -53.50% | -62.85% | -72.15% |
| Treasury Stock & Other | -88.73% | 191.80% | 77.31% | 130.29% | 173.53% |
| Total Common Equity | -34.36% | -36.91% | 12.07% | 34.03% | 30.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.36% | -36.91% | 12.07% | 34.03% | 30.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.36% | -36.91% | 12.07% | 34.03% | 30.75% |
|
|
|||||